Prevalence of Elements of Shared Decision Making in PSA Screening Study Population (N=3,427), 2010 National Health Interview Survey
| Element, No. Responding | Percenta |
|---|---|
| Discussion of advantages/disadvantages, n = 3,344 | |
| None | 65.1 |
| Advantages only | 16.9 |
| Disadvantages only | 0.9 |
| Both | 17.0 |
| Discussion of uncertainty, n = 3,344 | |
| Yes | 12.1 |
| No | 87.9 |
| Extent of shared decision making,b n=3,304 | |
| No elements | 64.3 |
| Partial, disadvantages only, disadvantages and uncertainty, or uncertainty only | 2.5 |
| Partial, advantages only | 14.6 |
| Partial, advantages and disadvantages or advantages and uncertainty | 10.7 |
| All elements | 8.0 |
PSA=prostate-specific antigen.
Note: Respondents were men aged 40–75 years with no prior PSA testing or who had PSA testing as part of routine examination (N = 3,427); not all categories sum to 3,427 because of missing data.
↵a Percentages weighted to the US civilian noninstitutionalized population.
↵b Physician discussion of the following elements: advantages, disadvantages, and uncertainty.